File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Optimal systolic blood pressure target for hypertensive patients: a network meta-analysis

TitleOptimal systolic blood pressure target for hypertensive patients: a network meta-analysis
Authors
Issue Date2017
PublisherExcerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinthera
Citation
The 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Prague, Czech Republic, 24-27 June 2017. In Clinical Therapeutics, 2017, v. 39 n. 8S, p. e81 How to Cite?
AbstractBackground Intensive blood pressure (BP)-lowering to <120 mmHg has recently been shown to reduce mortality and cardiovascular (CV) events in hypertensive patients without diabetes. This challenges existing guidelines. We therefore used network meta-analysis to study the relationship between achieved BP target and outcomes. Methods We searched for randomised controlled trials (RCTs) of different BP targets that reported CV events. The achieved systolic BP (SBP) in different trials was classified into five groups (110-119, 120-129, 130-139, 140-149 and 150-159 mmHg). Frequentist approach and Bayesian framework were used. Results Thirteen RCTs with altogether 48,152 patients were included. All patients were over 50 years old. Stroke and major adverse CV events were reduced when controlling SBP to 120-129 mmHg compared to 130-139 mmHg (OR 0.83, 95% CI 0.69-0.99 and 0.84, 0.73-0.96), 140-149 mmHg (0.70, 0.55-0.90 and 0.75, 0.63-0.90), and 150-159 mmHg (0.39, 0.23-0.67 and 0.42, 0.31-0.58), respectively. More intensive control to <120 mmHg also reduced stroke (0.58, 0.38-0.87, 0.49, 0.31-0.77, and 0.27, 0.14-0.52). In contrast, SBP target of ≥150 mmHg increased myocardial infarction (MI) and CV mortality compared to 120-129 mmHg (1.73, 1.08-2.78 and 2.05, 1.27-3.30) and 130-139 mmHg (1.53, 1.03-2.29 and 1.60, 1.08-2.39). No significant effect of target SBP on all-cause mortality was found. Conclusions Intensive BP-lowering reduces stroke and to a lesser extent, MI. CV mortality is higher if SBP exceeds 150 mmHg. Our network meta-analysis supports a SBP target of 120-130 mmHg for hypertensive patients over 50 years old.
Persistent Identifierhttp://hdl.handle.net/10722/247883
ISSN
2017 Impact Factor: 3.185
2015 SCImago Journal Rankings: 0.997

 

DC FieldValueLanguage
dc.contributor.authorFei, Y-
dc.contributor.authorTsoi, MF-
dc.contributor.authorCheung, TT-
dc.contributor.authorCheung, BMY-
dc.date.accessioned2017-10-18T08:34:12Z-
dc.date.available2017-10-18T08:34:12Z-
dc.date.issued2017-
dc.identifier.citationThe 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Prague, Czech Republic, 24-27 June 2017. In Clinical Therapeutics, 2017, v. 39 n. 8S, p. e81-
dc.identifier.issn0149-2918-
dc.identifier.urihttp://hdl.handle.net/10722/247883-
dc.description.abstractBackground Intensive blood pressure (BP)-lowering to <120 mmHg has recently been shown to reduce mortality and cardiovascular (CV) events in hypertensive patients without diabetes. This challenges existing guidelines. We therefore used network meta-analysis to study the relationship between achieved BP target and outcomes. Methods We searched for randomised controlled trials (RCTs) of different BP targets that reported CV events. The achieved systolic BP (SBP) in different trials was classified into five groups (110-119, 120-129, 130-139, 140-149 and 150-159 mmHg). Frequentist approach and Bayesian framework were used. Results Thirteen RCTs with altogether 48,152 patients were included. All patients were over 50 years old. Stroke and major adverse CV events were reduced when controlling SBP to 120-129 mmHg compared to 130-139 mmHg (OR 0.83, 95% CI 0.69-0.99 and 0.84, 0.73-0.96), 140-149 mmHg (0.70, 0.55-0.90 and 0.75, 0.63-0.90), and 150-159 mmHg (0.39, 0.23-0.67 and 0.42, 0.31-0.58), respectively. More intensive control to <120 mmHg also reduced stroke (0.58, 0.38-0.87, 0.49, 0.31-0.77, and 0.27, 0.14-0.52). In contrast, SBP target of ≥150 mmHg increased myocardial infarction (MI) and CV mortality compared to 120-129 mmHg (1.73, 1.08-2.78 and 2.05, 1.27-3.30) and 130-139 mmHg (1.53, 1.03-2.29 and 1.60, 1.08-2.39). No significant effect of target SBP on all-cause mortality was found. Conclusions Intensive BP-lowering reduces stroke and to a lesser extent, MI. CV mortality is higher if SBP exceeds 150 mmHg. Our network meta-analysis supports a SBP target of 120-130 mmHg for hypertensive patients over 50 years old.-
dc.languageeng-
dc.publisherExcerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinthera-
dc.relation.ispartofClinical Therapeutics-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleOptimal systolic blood pressure target for hypertensive patients: a network meta-analysis-
dc.typeConference_Paper-
dc.identifier.emailCheung, TT: tcheungt@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityCheung, TT=rp01682-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.doi10.1016/j.clinthera.2017.05.249-
dc.identifier.hkuros282103-
dc.identifier.volume39-
dc.identifier.issue8S-
dc.identifier.spagee81-
dc.identifier.epagee81-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats